Francesca Girolami

Author PubWeight™ 14.48‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Myofilament protein gene mutation screening and outcome of patients with hypertrophic cardiomyopathy. Mayo Clin Proc 2008 2.80
2 [Management of refractory symptoms in hypertrophic cardiomyopathy with restrictive pathophysiology: novel perspectives for ranolazine]. G Ital Cardiol (Rome) 2012 1.38
3 The familial hypertrophic cardiomyopathy-associated myosin mutation R403Q accelerates tension generation and relaxation of human cardiac myofibrils. J Physiol 2008 1.14
4 Relevance of coronary microvascular flow impairment to long-term remodeling and systolic dysfunction in hypertrophic cardiomyopathy. J Am Coll Cardiol 2006 1.13
5 Microvascular function is selectively impaired in patients with hypertrophic cardiomyopathy and sarcomere myofilament gene mutations. J Am Coll Cardiol 2011 1.03
6 Prevalence and clinical profile of troponin T mutations among patients with hypertrophic cardiomyopathy in tuscany. Am J Cardiol 2003 0.95
7 Efficacy of catheter ablation for atrial fibrillation in hypertrophic cardiomyopathy: impact of age, atrial remodelling, and disease progression. Europace 2010 0.94
8 The many faces of hypertrophic cardiomyopathy: from developmental biology to clinical practice. J Cardiovasc Transl Res 2009 0.92
9 Prognostic value of N-terminal pro-brain natriuretic Peptide in outpatients with hypertrophic cardiomyopathy. Am J Cardiol 2013 0.78
10 Coincident chronic inflammatory demyelinating polyneuropathy and focal segmental glomerulosclerosis: a common autoimmunity? Clin Exp Nephrol 2010 0.78
11 [Clinical and genetic features of left ventricular noncompaction: a continuum in cardiomyopathies]. G Ital Cardiol (Rome) 2010 0.76
12 Fulminant multifocal motor neuropathy: a report of two cases. Int J Neurosci 2012 0.76
13 [Disease progression and systolic dysfunction in patients with hypertrophic cardiomyopathy: genetic basis, pathophysiology and clinical presentation]. G Ital Cardiol (Rome) 2011 0.76
14 Identification of seven novel mutations of F8C by DHPLC. Hum Mutat 2002 0.75
15 An Investigation of the Molecular Mechanism of Double cMyBP-C Mutation in a Patient with End-Stage Hypertrophic Cardiomyopathy. J Cardiovasc Transl Res 2015 0.75
16 Looking for hypertrophic cardiomyopathy in the community: why is it important? J Cardiovasc Transl Res 2009 0.75
17 Acute-onset multifocal motor neuropathy (AMMN): how we meet the diagnosis. Int J Neurosci 2012 0.75
18 [A new type of "tracing" for cardiologists?]. G Ital Cardiol (Rome) 2009 0.75